Ocular complications in 2 cases with porphyria

Cornea

Volumn 27, Issue 9, 2008, Pages 1093-1096

  Altiparmak, Ugur E ^a,b   Oflu, Yusuf ^a   Kocaoglu, Fatma Akbas ^a   Katircioglu, Yasemin Aslan ^a   Duman, Sunay ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Naci Cakir Mahallesi   (Turkey)

Author keywords

Amniotic membrane; Porphyria; Scleral necrosis

Indexed keywords

AMIKACIN; AMINOLEVULINIC ACID; COPROPORPHYRIN; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; METHYLPREDNISOLONE; PORPHOBILINOGEN; PREDNISOLONE ACETATE; PROTOPORPHYRIN; STEROID; TEARS NATURALE; TEARS NATURALE FREE; UNCLASSIFIED DRUG; VANCOMYCIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AMNION; ANAMNESIS; ANTERIOR EYE CHAMBER; ARTICLE; CASE REPORT; CHEMOSIS; CONGENITAL ERYTHROPOIETIC PORPHYRIA; CORNEA LIMBUS; CORNEA NECROSIS; CORNEA OPACITY; DRUG DOSE REDUCTION; ECTROPION; ENDOPHTHALMITIS; EVISCERATION; EYE BURNING; EYE FUNDUS; EYE PAIN; EYE PROTECTION; EYE SYNECHIA; EYELID EDEMA; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PHOTOPHOBIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SCLERA DISEASE; SKIN TRANSPLANTATION; SPECTACLES; TENODESIS; VISUAL ACUITY; VISUAL IMPAIRMENT; EYE DISEASE; EYE SURGERY; MIDDLE AGED; NECROSIS; PAIN; PATHOLOGY; SCLERA; TOPICAL DRUG ADMINISTRATION; TRANSPLANTATION;

ADMINISTRATION, TOPICAL; ADULT; AMNION; ENDOPHTHALMITIS; EYE DISEASES; EYE EVISCERATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NECROSIS; PAIN; PHOTOPHOBIA; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ERYTHROPOIETIC; SCLERA;

EID: 58149159941     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31817e905a     Document Type: Article

References (12)

1. Meyer UA. Porphyria. In: Braunwald E, Issebacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill; 1994:2073-2079.
2. Chumbley LC. Scleral involvement in symptomatic porphyria. Am J Ophthalmol. 1977;84:729-733.
3. Oguz F, Sidal M, Bayram C, et al. Ocular involvement in two symptomatic congenital erythropoietic porphyria. Eur J Pediatr. 1993;152:671-673.
4. Tanigawa K, Takamura N, Nakata K, et al. Ocular complication in congenital erythropoietic porphyria. Ophtalmologica. 1996;210:183-185.
5. Venkatesh P, Garg SP, Kumaran E, et al. Congenital porphyria with necrotizing scleritis in a 9-year-old child. Clin Experiment Ophthalmol. 2000;28:314-318.
6. Kurihara K, Takamura N, Imaizumi S, et al. Ocular involvement caused by the accumulation of porphyrins in a patient with congenital erythropoietic porphyria. Br J Ophthalmol. 2001;85:1260
7. Veenashree MP, Sangwan V, Vemuganti G, et al. Acute scleritis as a manifestation of congenital erythropoietic porphyria. Cornea. 2002;21: 530-535.
8. Bhutani LK, Sood SK, Das PK, et al. Congenital erythropoietic porphyria: an autopsy report. Arch Dermatol. 1974;110:427-431.
9. Poh-Fitzpatrick MB. The erythropoietic porphyrias. Dermatol Clin. 1986; 4:291-295.
10. Kappas A, Sass S, Anderson KE. The metabolic basis of inherited disease. In: Scrivner Jr, ed. The Porphyrias. New York, NY: McGraw-Hill; 1989: 1305-1365.
11. Garey JR, Hansen JL, Harrison LM, et al. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda. Blood. 1989;73:892.
12. Garey JR, Harrison LM, Franklin KF, et al. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda. J Clin Invest. 1990;86: 1416.